Pneumococcal pep27 mutant immunization suppresses allergic asthma in mice

Area of Science:

• Immunology
• Allergology
• Microbiology

Background:

• Asthma is an allergic airway disease (AAD) driven by immune dysregulation.
• Regulatory T cells (Tregs) are crucial for immune homeostasis.
• Streptococcus pneumoniae components and infection may induce Tregs, offering therapeutic potential for asthma.

Purpose of the Study:

• To investigate the potential of a live attenuated Streptococcus pneumoniae pep27 deletion mutant (Δpep27) vaccine for asthma protection.
• To evaluate the efficacy of intranasal Δpep27 immunization in a mouse model of allergic airway disease.

Main Methods:

• Mice were immunized intranasally with Δpep27 before or after ovalbumin sensitization and challenge.
• Hallmark features of allergic airway disease were assessed, including immune cell infiltration, cytokine production, and airway remodeling.

Main Results:

• Δpep27 immunization significantly suppressed key asthma indicators.
• This included reduced antigen-specific type 2 helper T cell responses and antibody production.
• Pulmonary eosinophil accumulation and goblet cell hyperplasia were also suppressed.

Conclusions:

• Intranasal Δpep27 immunization effectively ameliorated allergic airway disease in a mouse model.
• The Δpep27 vaccine demonstrates feasibility as a preventive or therapeutic agent for asthma.
• Further research into Δpep27's immunomodulatory mechanisms is warranted.